Overview

The European and Developing Countries Clinical Trials Partnership (EDCTP) was established in 2003. The first programme phase (EDCTP1) was implemented in 2004-2015 and the second (EDCTP2) started in 2014 as part of the EU’s research and innovation funding programme Horizon 2020, and ends 2024. Sweden has through Sida contributed to EDCTP and Sida has in accordance with government decisions UD2003/5304-4/GU (2003-10-23) and UF2015/12547/UD/USTYR (2015-02-26) represented Sweden in EDCTP1 and EDCTP2…

Involved parties

:
-
:
EDCTP/European & Developing Countries Clinical Trials Partnership
:
EDCTP/European & Developing Countries Clinical Trials Partnership
:
  • B03 - Contributions to specific-purpose programmes and funds managed by international organisations (multilateral, INGO)

Strategies governing the contribution

  1. Research cooperation 2022-20283,143,418 SEK 100% of total

Geographical allocation of the contribution

No countries have been assigned to this contribution.

Development areas for the contribution

No development areas have been assigned to this contribution.

Duration of the contribution

January 1, 2023
December 31, 2028
Ongoing

Committed and disbursed amount

Agreed amount SEK 3,440,000

Paid amount SEK 3,143,418

Paid per year (net value)

  • 2023: SEK 1,198,588
  • 2024: SEK 423,118
  • 2025: SEK 997,680
  • 2026: SEK 524,032

Sustainable Development Goals

The contributions contribution to the UN's global sustainability goals.

  • Global Goals, goal 3: Good health and well-being